`Anti-alcoholism` drug cleared for use in France
Paris: French health authorities have approved the use of a drug, originally designed to treat nervous spasms, for the treatment of alcoholism on a "case by case" basis.
AFSSAPS, the regulator that authorises drugs, said that while the drug Baclofen had not been definitively shown to be efficient in the treatment of alcoholism, it had shown "clinical benefits in some patients".
It recommended in a statement that Baclofen -- the lab name for a medication branded as Kemstro, Lioresal and Gablofen -- should be considered on a "case by case" basis.
The history of the drug goes back 50 years. It was originally designed for epilepsy before becoming licensed to treat spasticity, but researchers are now interested in using it to ease alcoholic craving.
Interest was sparked in 2008 by a book, "Le Dernier Verre" (The Last Drink), by cardiologist Olivier Ameisen, who self-treated his alcoholism with high doses of Baclofen.
The AFSSAPS statement came after French doctors said last month that the drug had cleared an important early test. The trial entailed enrolling 132 heavy drinkers who were given Baclofen at high doses over a year.
Eighty percent either became abstinent or turned into moderate drinkers. By comparison, two drugs that are commonly used to treat alcoholics, naltrexon and acamprosate, yield a success rate of 20-25 per cent.
Side effects included fatigue, drowsiness, insomnia, dizziness and digestive troubles.
Lead researcher Philippe Jaury of the University of Paris-Descartes said the outcome opened the door to one-year clinical trials, expected to start in May, in which 320 alcoholics would be divided into two groups.
One batch will receive Baclofen, progressively building in dosage until the craving symptoms subside, while the others will receive an inactive look-a-like pill, or placebo.
France`s health system is paying 750,000 euros (USD 469,000) of the 1.2-million-euro (USD 1.45-million) cost of the trial, and an unidentified donor is paying the rest, said Jaury.
The pre-trial study was published in a specialist journal, Alcohol and Alcoholism.
More from India
More from World
More from Sports
More from Entertaiment
- Salman's controversial tweet on Yakub Memon a 'contempt of court'?
- Know the significance of Devshayani Ekadashi
- Lalu Prasad Yadav calls PM Modi ''Kans'', BJP ''Bharat Jalao Party''
- What's the motive behind politicising Yakub Memon's death penalty?
- Punjab: Terrorists in Army uniform attack police station in Gurdaspur
- Watch: Yuvraj Singh takes up Shoaib Malik's challenge, puts on his dancing shoes
- SC to resume hearing on Mumbai blasts convict Yakub Memon's mercy plea on Tuesday
- Lalu Prasad Yadav arrested as RJD bandh cripples life in Bihar
- Exercise, healthy food prevent knee pain in adults with diabetes
- Politicos mourn death of former president APJ Abdul Kalam, hail him as 'Missile Man of India'